Major Developments: Brain Activate-B (06681) has signed significant business cooperation agreements with Peking University Sixth Hospital and Shandong Mental Health Center, respectively. Concord New Energy (00182) has successfully completed its secondary listing on the Singapore Exchange. Cloudbreak-B (02592) has successfully submitted a new drug clinical trial application for CBT-009 to the Center for Drug Evaluation. Wing Tung Holdings (06883) has established a partnership with the Italian high-end fragrance brand CULTI, aiming to strengthen its high-end fragrance distribution network in China. Weimob Group (02013) has initiated business cooperation with Taobao Flash Sales. Dalipal Holdings (01921) has officially become a qualified supplier for Saudi Aramco. Immuncell-B (01541) has regained global rights for IMM2510 and IMM27M. Yuexiu Property (00123)'s subsidiary, Shanghai Yueheng, successfully acquired a land parcel in Pudong New Area, Shanghai.

Operating Performance: Jinxin Fertility (01951) reported that the overall decline in IVF egg retrieval cycles for 2025 further narrowed to -1.4%. Poly Property Group (00119) achieved cumulative contracted sales amounting to approximately RMB 50.2 billion in 2025, a decrease of 7.38% year-on-year. YADEA (01585) issued a profit alert, expecting an annual net profit of no less than RMB 2.9 billion. Gemdale Properties (00535)'s total cumulative contracted sales for 2025 were approximately RMB 10.696 billion, a decrease of 47.33% year-on-year. Greentown Management Holdings (09979) estimated the project management fees for newly secured projects in 2025 to be RMB 9.35 billion, an increase of about 0.4% year-on-year. Sunac China (01918) achieved cumulative contracted sales of approximately RMB 36.84 billion in 2025, a decrease of 21.85% year-on-year.